Post-transcriptional regulation of gene expression in innate immunity

Nature Reviews Immunology

Volumn 14, Issue 6, 2014, Pages 361-376

  Carpenter, Susan ^a   Ricci, Emiliano P ^b   Mercier, Blandine C ^b   Moore, Melissa J ^b   Fitzgerald, Katherine A ^a,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INITIATION FACTOR 2; INITIATION FACTOR 4E; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LONG UNTRANSLATED RNA; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; POLYNUCLEOTIDE ADENYLYLTRANSFERASE; RANTES; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AU RICH ELEMENT; CELL DIFFERENTIATION; CONFORMATIONAL TRANSITION; DENDRITIC CELL; DISEASE DURATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; EXON SKIPPING; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTRON RETENTION; MACROPHAGE; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; RNA PROCESSING; RNA SEQUENCE; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION;

ADAPTIVE IMMUNITY; ALTERNATIVE SPLICING; ANIMALS; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; POLYADENYLATION; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84901315841     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3682     Document Type: Review

References (136)

1. Aringer, M., Gunther, C. & Lee-Kirsch, M. A. Innate immune processes in lupus erythematosus. Clin. Immunol. 147, 216-222 (2013).
2. Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nature Rev. Immunol. 13, 709-721 (2013).
3. Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30, 16-34 (2011).
4. Thompson, M. R., Kaminski, J. J., Kurt-Jones, E. A. & Fitzgerald, K. A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3, 920-940 (2011).
5. Medzhitov, R. & Horng, T. Transcriptional control of the inflammatory response. Nature Rev. Immunol. 9, 692-703 (2009).
6. Smale, S. T. Transcriptional regulation in the innate immune system. Curr. Opin. Immunol. 24, 51-57 (2012).
7. Rodrigues, R., Grosso, A. R. & Moita, L. Genome-wide analysis of alternative splicing during dendritic cell response to a bacterial challenge. PLoS ONE 8, e61975 (2013).
8. Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320, 1643-1647 (2008). (Pubitemid 351931255)
9. Moore, M. J. & Proudfoot, N. J. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 136, 688-700 (2009).
10. Elkon, R., Ugalde, A. P. & Agami, R. Alternative cleavage and polyadenylation: extent, regulation and function. Nature Rev. Genet. 14, 496-506 (2013).
11. Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476 (2008). (Pubitemid 352759009)
12. Miura, P., Shenker, S., Andreu-Agullo, C., Westholm, J. O. & Lai, E. C. Widespread and extensive lengthening of 3′ UTRs in the mammalian brain. Genome Res. 23, 812-825 (2013).
13. Wells, C. A. et al. Alternate transcription of the Toll-like receptor signaling cascade. Genome Biol. 7, R10 (2006).
14. Jarešová, I. et al. Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. Microbes Infect. 9, 1359-1367 (2007). (Pubitemid 47539210)
15. Iwami, K. I. et al. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165, 6682-6686 (2000).
16. Stevenson, B. J., Iseli, C., Beutler, B. & Jongeneel, C. V. Use of transcriptome data to unravel the fine structure of genes involved in sepsis. J. Infect. Dis. 187 (Suppl. 2), 308-314 (2003).
17. Chang, J.-S. et al. Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. J. Immunol. 176, 3010-3018 (2006).
18. Haehnel, V., Schwarzfischer, L., Fenton, M. J. & Rehli, M. Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168, 5629-5637 (2002). (Pubitemid 34556144)
19. Ohta, S., Bahrun, U., Tanaka, M. & Kimoto, M. Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling. Biochem. Biophys. Res. Commun. 323, 1103-1108 (2004). (Pubitemid 39243432)
20. Gray, P. et al. Identification of a novel human MD-2 splice variant that negatively regulates lipopolysaccharide-induced TLR4 signaling. J. Immunol. 184, 6359-6366 (2010).
21. Burns, K. et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197, 263-268 (2003). (Pubitemid 36152320)
22. Janssens, S., Burns, K., Tschopp, J. & Beyaert, R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88. Curr. Biol. 12, 467-471 (2002). (Pubitemid 34248892)
23. Janssens, S., Burns, K., Vercammen, E., Tschopp, J. & Beyaert, R. MyD88S, a splice variant of MyD88, differentially modulates NF-κB-and AP-1-dependent gene expression. FEBS Lett. 548, 103-107 (2003). (Pubitemid 37281258)
24. Jensen, L. E. & Whitehead, A. S. IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J. Biol. Chem. 276, 29037-29044 (2001).
25. Yanagisawa, K. et al. A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-κB (NF-κB) and c-Jun N-terminal kinase (JNK). Biochem. J. 370, 159-166 (2003). (Pubitemid 36259428)
26. Rao, N., Nguyen, S., Ngo, K. & Fung-Leung, W.-P. A novel splice variant of interleukin-1 receptor (IL-1R)- associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol. Cell. Biol. 25, 6521-6532 (2005). (Pubitemid 41023227)
27. Hardy, M. P. & O'Neill, L. A. J. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279, 27699-27708 (2004). (Pubitemid 38812611)
28. Leeman, J. R. & Gilmore, T. D. Alternative splicing in the NF-κB signaling pathway. Gene 423, 97-107 (2008).
29. Han, K.-J., Yang, Y., Xu, L.-G. & Shu, H.-B. Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling. J. Biol. Chem. 285, 12543-12550 (2010).
30. Palsson-McDermott, E. M. et al. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nature Immunol. 10, 579-586 (2009).
31. Karpova, A. Y., Ronco, L. V. & Howley, P. M. Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3. Mol. Cell. Biol. 21, 4169-4176 (2001). (Pubitemid 32565299)
32. Li, C., Ma, L. & Chen, X. Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3. Cell. Mol. Immunol. 8, 67-74 (2011).
33. Li, Y. et al. Identification of novel alternative splicing variants of interferon regulatory factor 3. Biochim. Biophys. Acta 1809, 166-175 (2011).
34. Shell, S. A., Hesse, C., Morris, S. M. & Milcarek, C. Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide- stimulated macrophages influence gene expression and induce alternative poly(A) site selection. J. Biol. Chem. 280, 39950-39961 (2005). (Pubitemid 41779130)
35. Bhatt, D. M. et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 150, 279-290 (2012).
36. Hao, S. & Baltimore, D. RNA splicing regulates the temporal order of TNF-induced gene expression. Proc. Natl Acad. Sci. USA 110, 11934-11939 (2013).
37. Rabani, M. et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nature Biotech. 29, 436-442 (2011).
38. Paulsen, M. T. et al. Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response. Proc. Natl Acad. Sci. USA 110, 2240-2245 (2013).
39. Elkon, R., Zlotorynski, E., Zeller, K. I. & Agami, R. Major role for mRNA stability in shaping the kinetics of gene induction. BMC Genomics 11, 259 (2010).
40. Hao, S. & Baltimore, D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nature Immunol. 10, 281-288 (2009).
41. Caput, D. et al. Identification of a common nucleotide sequence in the 3′ untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl Acad. Sci. USA 83, 1670-1674 (1986). (Pubitemid 16018626)
42. Shaw, G. & Kamen, R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667 (1986).
43. Bakheet, T., Williams, B. R. & Khabar, K. S. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res. 34, D111-114 (2006).
44. Halees, A. S., El-Badrawi, R. & Khabar, K. S. ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse. Nucleic Acids Res. 36, D137-D140 (2008). (Pubitemid 351149710)
45. Beisang, D. & Bohjanen, P. R. Perspectives on the ARE as it turns 25 years old. Wiley Interdiscip. Rev. RNA 3, 719-731 (2012).
46. Ivanov, P. & Anderson, P. Post-transcriptional regulatory networks in immunity. Immunol. Rev. 253, 253-272 (2013).
47. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F. & Kollias, G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387-398 (1999). (Pubitemid 29165293)
48. Chen, Y.-L. et al. Differential regulation of ARE-mediated TNFα and IL-1β mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem. Biophys. Res. Commun. 346, 160-168 (2006). (Pubitemid 43865980)
49. Stoecklin, G. et al. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23, 1313-1324 (2004). (Pubitemid 38525003)
50. Sun, L. et al. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-α mRNA. J. Biol. Chem. 282, 3766-3777 (2007). (Pubitemid 47084478)
51. Lu, J.-Y., Sadri, N. & Schneider, R. J. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev. 20, 3174-3184 (2006). (Pubitemid 44790631)
52. Taylor, G. A. et al. A pathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4, 445-454 (1996). (Pubitemid 26354654)
53. Carballo, E., Lai, W. S. & Blackshear, P. J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95, 1891-1899 (2000). (Pubitemid 30151623)
54. Sadri, N. & Schneider, R. J. Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. J. Invest. Dermatol. 129, 657-670 (2009).
55. Yiakouvaki, A. et al. Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. J. Clin. Invest. 122, 48-61 (2012).
56. Stoecklin, G., Lu, M., Rattenbacher, B. & Moroni, C. A constitutive decay element promotes tumor necrosis factor alpha mRNA degradation via an AU-rich element-independent pathway. Mol. Cell. Biol. 23, 3506-3515 (2003). (Pubitemid 36539183)
57. Moraes, K. C. M., Wilusz, C. J. & Wilusz, J. CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA 12, 1084-1091 (2006). (Pubitemid 43788126)
58. Pautz, A. et al. The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression. J. Biol. Chem. 281, 32294-32302 (2006). (Pubitemid 46036783)
59. Fabian, M. R. & Sonenberg, N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nature Struct. Mol. Biol. 19, 586-593 (2012).
60. Kozomara, A. & Griffiths-Jones, S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39, D152-D157 (2011).
61. Friedman, R. C., Farh, K. K.-H., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009).
62. O'Connell, R. M. & Rao, D. S. & Baltimore, D. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30, 295-312 (2012).
63. Li, Y. & Shi, X. MicroRNAs in the regulation of TLR and RIG-I pathways. Cell. Mol. Immunol. 10, 65-71 (2013).
64. Bicknell, A. A., Cenik, C., Chua, H. N., Roth, F. P. & Moore, M. J. Introns in UTRs: why we should stop ignoring them. Bioessays 34, 1025-1034 (2012).
65. Weischenfeldt, J. et al. NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev. 22, 1381-1396 (2008). (Pubitemid 351717528)
66. Lelouard, H. et al. Regulation of translation is required for dendritic cell function and survival during activation. J. Cell Biol. 179, 1427-1439 (2007).
67. Donnelly, N., Gorman, A. M., Gupta, S. & Samali, A. The eIF2α kinases: their structures and functions. Cell. Mol. Life Sci. 70, 3493-3511 (2013).
68. He, B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 13, 393-403 (2006).
69. Woo, C. W. et al. Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nature Cell Biol. 11, 1473-1480 (2009).
70. Woo, C. W., Kutzler, L., Kimball, S. R. & Tabas, I. Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B. Nature Cell Biol. 14, 192-200 (2012).
71. Furic, L. et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc. Natl Acad. Sci. USA 107, 14134-14139 (2010).
72. Kleijn, M., Vrins, C. L., Voorma, H. O. & Thomas, A. A. Phosphorylation state of the cap-binding protein eIF4E during viral infection. Virology 217, 486-494 (1996).
73. Herdy, B. et al. Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E. Nature Immunol. 13, 543-550 (2012).
74. Wan, Y. et al. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J. Biol. Chem. 284, 10367-10375 (2009).
75. Zhou, H. et al. IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production. EMBO J. 32, 583-596 (2013).
76. Kim, W. J., Kim, J. H. & Jang, S. K. Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. EMBO J. 26, 5020-5032 (2007). (Pubitemid 350261283)
77. Schmitz, F. et al. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 38, 2981-2992 (2008).
78. Colina, R. et al. Translational control of the innate immune response through IRF-7. Nature 452, 323-328 (2008). (Pubitemid 351430792)
79. López-Pelaéz, M. et al. Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages. Mol. Biol. Cell 23, 2982-2992 (2012).
80. Jefferies, H. B. et al. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J. 16, 3693-3704 (1997). (Pubitemid 27250062)
81. Jaramillo, M. et al. Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 9, 331-341 (2011).
82. Weichhart, T. et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565-577 (2008).
83. Ivanov, S. S. & Roy, C. R. Pathogen signatures activate a ubiquitination pathway that modulates the function of the metabolic checkpoint kinase mTOR. Nature Immunol. 14, 1219-1228 (2013).
84. Jackson, R. J., Hellen, C. U. T. & Pestova, T. V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nature Rev. Mol. Cell. Biol. 11, 113-127 (2010).
85. Weill, L., Belloc, E., Bava, F.-A. & Méndez, R. Translational control by changes in poly(A) tail length: recycling mRNAs. Nature Struct. Mol. Biol. 19, 577-585 (2012).
86. Crawford, E. K., Ensor, J. E., Kalvakolanu, I. & Hasday, J. D. The role of 3′ poly(A) tail metabolism in tumor necrosis factor-α regulation. J. Biol. Chem. 272, 21120-21127 (1997). (Pubitemid 27373971)
87. Swanson, B. J., Murakami, M., Mitchell, T. C., Kappler, J. & Marrack, P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17, 605-615 (2002). (Pubitemid 35351506)
88. Groppo, R. & Richter, J. D. CPEB control of NF-κB nuclear localization and interleukin-6 production mediates cellular senescence. Mol. Cell. Biol. 31, 2707-2714 (2011).
89. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148 (1987).
90. Shinohara, M. L., Kim, H.-J., Kim, J.-H., Garcia, V. A. & Cantor, H. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc. Natl Acad. Sci. USA 105, 7235-7239 (2008). (Pubitemid 351754461)
91. Kozak, M. Constraints on reinitiation of translation in mammals. Nucleic Acids Res. 29, 5226-5232 (2001). (Pubitemid 34065441)
92. Calvo, S. E., Pagliarini, D. J. & Mootha, V. K. Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc. Natl Acad. Sci. USA 106, 7507-7512 (2009).
93. Brubaker, S. W., Gauthier, A. E., Mills, E. W., Ingolia, N. T. & Kagan, J. C. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell 156, 800-811 (2014).
94. Lang, K. J. D., Kappel, A. & Goodall, G. J. Hypoxia-inducible factor-1α mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol. Biol. Cell 13, 1792-1801 (2002). (Pubitemid 34522656)
95. Wang, G., Guo, X., Silveyra, P., Kimball, S. R. & Floros, J. Cap-independent translation of human SP-A 5′-UTR variants: a double-loop structure and cis-element contribution. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L635-L647 (2009).
96. Rübsamen, D. et al. IRES-dependent translation of egr2 is induced under inflammatory conditions. RNA 18, 1910-1920 (2012).
97. Rübsamen, D. et al. Inflammatory conditions induce IRES-dependent translation of cyp24a1. PLoS ONE 9, e85314 (2014).
98. Leppek, K. & Stoecklin, G. An optimized streptavidin-binding RNA aptamer for purification of ribonucleoprotein complexes identifies novel ARE-binding proteins. Nucleic Acids Res. 42, e13 (2013).
99. Tiedje, C. et al. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet. 8, e1002977 (2012).
100. Qi, M.-Y. et al. AU-rich-element-dependent translation repression requires the cooperation of tristetraprolin and RCK/P54. Mol. Cell. Biol. 32, 913-928 (2012).
101. Piecyk, M. et al. TIA-1 is a translational silencer that selectively regulates the expression of TNF-α. EMBO J. 19, 4154-4163 (2000). (Pubitemid 30608553)
102. Anderson, P. & Kedersha, N. Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation. Cell Stress Chaperones 7, 213-221 (2002). (Pubitemid 36133473)
103. Damgaard, C. K. & Lykke-Andersen, J. Translational coregulation of 5' TOP mRNAs by TIA-1 and TIAR. Genes Dev. 25, 2057-2068 (2011).
104. Mazumder, B. & Fox, P. L. Delayed translational silencing of ceruloplasmin transcript in gamma interferon-activated U937 monocytic cells: role of the 3′ untranslated region. Mol. Cell. Biol. 19, 6898-6905 (1999). (Pubitemid 29441872)
105. Sampath, P., Mazumder, B., Seshadri, V. & Fox, P. L. Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3' untranslated region. Mol. Cell. Biol. 23, 1509-1519 (2003). (Pubitemid 36246034)
106. Sampath, P. et al. Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell 119, 195-208 (2004). (Pubitemid 39360902)
107. Mazumder, B. et al. Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell 115, 187-198 (2003). (Pubitemid 37329582)
108. Kapasi, P. et al. L13a blocks 48S assembly: role of a general initiation factor in mRNA-specific translational control. Mol. Cell 25, 113-126 (2007). (Pubitemid 46049063)
109. Vyas, K. et al. Genome-wide polysome profiling reveals an inflammation-responsive posttranscriptional operon in gamma interferon-activated monocytes. Mol. Cell. Biol. 29, 458-470 (2008).
110. Mukhopadhyay, R. et al. DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression. Mol. Cell 32, 371-382 (2008).
111. Ray, P. S. & Fox, P. L. A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity. EMBO J. 26, 3360-3372 (2007). (Pubitemid 47123539)
112. Ray, P. S. et al. A stress-responsive RNA switch regulates VEGFA expression. Nature 457, 915-919 (2009).
113. Yao, P. et al. The HILDA complex coordinates a conditional switch in the 3′-untranslated region of the VEGFA mRNA. PLoS Biol. 11, e1001635 (2013).
114. González-Terán, B. et al. Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis. J. Clin. Invest. 123, 164-178 (2013).
115. Pachnis, V., Brannan, C. I. & Tilghman, S. M. The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J. 7, 673-681 (1988).
116. Brannan, C. I., Dees, E. C., Ingram, R. S. & Tilghman, S. M. The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10, 28-36 (1990).
117. Penny, G. D., Kay, G. F., Sheardown, S. A., Rastan, S. & Brockdorff, N. Requirement for Xist in X chromosome inactivation. Nature 379, 131-137 (1996). (Pubitemid 26020194)
118. Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
119. Rinn, J. L. & Chang, H. Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145-166 (2012).
120. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 5, 621-628 (2008). (Pubitemid 351911867)
121. Guttman, M. et al. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nature Biotech. 28, 503-510 (2010).
122. Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346 (2012).
123. Birney, E. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816 (2007). (Pubitemid 46920138)
124. Peng, X. et al. Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. mBio 1, e00206-e00210 (2010).
125. Ricci, E. P. et al. miRNA repression of translation in vitro takes place during 43S ribosomal scanning. Nucleic Acids Res. 41, 586-598 (2013).
126. Gomez, J. A. et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus. Cell 152, 743-754 (2013).
127. Collier, S. P., Collins, P. L., Williams, C. L., Boothby, M. R. & Aune, T. M. Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by TH1 cells. J. Immunol. 189, 2084-2088 (2012).
128. Carpenter, S. et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 341, 789-792 (2013).
129. Rapicavoli, N. A. et al. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife 2, e00762 (2013).
130. Li, Z. et al. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc. Natl Acad. Sci. USA 111, 1002-1007 (2014).
131. Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353-358 (2011).
132. Zong, X., Tripathi, V. & Prasanth, K. V. RNA splicing control: yet another gene regulatory role for long nuclear noncoding RNAs. RNA Biol. 8, 968-977 (2011).
133. Yin, Q. F. et al. Long noncoding RNAs with snoRNA ends. Mol. Cell 48, 219-230 (2012).
134. Faghihi, M. A. et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase. Nature Med. 14, 723-730 (2008).
135. Yoon, J.-H. et al. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 47, 648-655 (2012).
136. Yoon, J.-H., Abdelmohsen, K. & Gorospe, M. Posttranscriptional gene regulation by long noncoding RNA. J. Mol. Biol. 425, 3723-3730 (2013).